Health Care
-
Understanding the Legal Impact of Behavioral Health Parity: What the New Federal Rule Means for Your Organization
The Biden administration recently introduced a transformative federal rule aimed at reshaping the landscape of behavioral healthcare coverage. This rule underscores the critical need for…
-
Proposed HIPAA Cybersecurity Updates: What Healthcare Entities Need to Know
With cybersecurity threats escalating, particularly within healthcare, the Department of Health and Human Services (HHS) has proposed substantial updates to HIPAA’s Security Rule to align…
-
Supreme Court Denies Cert on Anti-Kickback Statute “Willfulness” Case
In a recent turn of events that has captured the attention of health care providers nationwide, the United States Supreme Court has opted not to…
-
Federal Court Ruling Signals Shift in False Claims Act Litigation: What Healthcare Providers Need to Know
In a recent landmark decision, a federal judge has declared certain provisions within the False Claims Act (FCA) unconstitutional, a ruling that could have significant…
-
Confronting Suicide in Construction: A Legal Perspective on Building a Healthier Industry
The construction industry, known for its demanding nature and unique challenges, is facing a mental health crisis. Recent studies indicate that construction workers experience suicide…
-
The Evolving Landscape of False Claims Act Litigation: What the Supervalu Ruling Means for Businesses
The False Claims Act (FCA) has long been a critical tool in addressing fraud against the government, particularly in the healthcare sector. But a recent…
-
HHS is not persuing an appeal of third party online tracking technologies for medical facilities.
In an important legal development for hospitals, the Department of Health and Human Services (HHS) has decided not to pursue its appeal of the June…
-
Legal Update: Supreme Court Overrules Chevron Doctrine
On Friday, the Supreme Court significantly limited the power of federal agencies to interpret the laws they administer, ruling that courts should rely on their…
-
Appeals Court Sides with Pharmaceutical Companies in 340B Case: An Analysis by DBL Law Partner David Dirr
In a significant ruling on May 21, 2024, the U.S. Court of Appeals for the District of Columbia upheld a lower court decision favoring pharmaceutical…
Subscribe To Our Legal Insights
By submitting this form, you are consenting to receive marketing emails from DBL Law. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.